Value of Total Lesion Glycolysis and Cell-of-origin Subtypes for Prognostic Stratification of Diffuse Large B-cell Lymphoma Patients.
Chong Jiang,Yue Teng,Zhong Zheng,Zhengyang Zhou,Jingyan Xu
DOI: https://doi.org/10.21037/qims-20-1166
2021-01-01
Quantitative Imaging in Medicine and Surgery
Abstract:Background: This study aimed to explore the added prognostic value of baseline metabolic volumetric parameters and cell of origin subtypes to the National Comprehensive Cancer Network International Prognostic Index (NCCN-IPI) in nodal diffuse large B-cell lymphoma (DLBCL) patients. Methods: A total of 184 consecutive de novo nodal DLBCL patients who underwent baseline positron emission tomography/computed tomography (PET/CT) were included in this study. Kaplan-Meier estimates were generated to evaluate the clinical, biological, and PET/CT parameters? prognostic value. The Cox proportional hazards model was performed to examine the potential independent predictors for progressionfree survival (PFS) and overall survival (OS). Results: With a median follow-up of 35 months, the 3-year PFS and OS were 65.2% and 73.0%, respectively. In univariate analysis, total lesion glycolysis (TLG), cell-of-origin subtypes, and NCCN-IPI were both PFS and OS predictors. High TLG (>= 1,852), non-germinal center B (non-GCB), as well as high NCCN-IPI (>= 4), were shown to be independently significantly associated with inferior PFS and OS after multivariate analysis. Based on the number of risk factors (high TLG, non-GCB, and high NCCN-IPI), a revised risk model was designed, and the participants were divided into four risk groups with very different outcomes, in which the PFS rates were 89.7%, 66.2%, 51.7%, and 26.7% (chi(2)=30.179, P<0.001), and OS rates were 93.1%, 73.8%, 56.7%, and 43.3%, respectively (chi(2)=23.649, P<0.001), respectively. Compared with the NCCN-IPI alone, the revised risk model showed a stronger ability to reveal further discrimination among subgroups, especially for participants with very unfavorable survival outcomes (PFS: chi(2)=9.963, P=0.002; OS: chi(2)=4.166, P=0.041, respectively). Conclusions: The TLG, cell-of-origin subtypes, and NCCN-IPI are independent prognostic survival factors in DLBCL patients. Moreover, the revised risk model composed of the number of risk factors (high TLG, non-GCB, and high NCCN-IPI) can stratify patients better than the NCCN-IPI, especially for patients at high risk, which suggests its potential integration into decision making for personalized medicine.